Fig. 3From: The prognostic significance of topoisomerase II alpha protein in early stage luminal breast cancerSubgroup survival analysis according to pathologic stage (a, b), molecular subtypes (c, d), and adjuvant therapy (e, f). Abbreviations: CT: chemotherapy; ET: endocrine therapyBack to article page